Conference Nordic HPB - NOLCA,

Hotel Norge, BERGEN

19 – 20 September 2024

Thursday 19 September

08.30                  Registration

09.00                  Welcome

09.10 – 10.30    Pancreatic Cancer

Chair: Jon-Helge Angelsen

Radiomics and Deep learning in Pancreatic cancer – Will AI replace the radiologist? Marjolein Henrieke Liedenbaum, Bergen

NORPACT-II and the way beyond for non metastatic PDAC Knut Jørgen Labori, Oslo

Clinical relevance of circulating tumor DNA in pancreatic cancer. Oddmund Nordgård, Stavanger

When to start or stop surveillance of 5 mm small IPMN? Claus Fristrup, Odense

10.30 – 11.00      Coffee/exhibition

  Endoscopy and Pancreatic Complications

Chair: Ernesto Sparrelid

11.00 – 11.20      Endoscopic ultrasound and FNB in cystic lesions (zoom link) Roald Havre, Bergen

11.20 - 11.40 EUS-guided Radiofrequency ablation of pancreatic NETs (zoom link) Khanh Do-Cong Pham, Bergen

11.40 - 12.00 Pancreatic fistula prediction, prevention, classification – Quo vadis?” Ville Sallinen, Helsinki

12.00 - 12.15 Complications in pancreatic surgery: Case presentations Dyre Kleive and Jon-Helge Angelsen, Bergen

12.15 - 12.30 Presidential adress. Roland Andersson, Lund

12.30 – 13.30      Lunch/exhibition

13.30 – 15.00   ROBOTIC /MINI INVASIVE HPB SURGERY

Chair: Bjørn Edwin

13.30 - 13.50 Establishing Robotic HPB surgery: Experience from Bergen. Jon-Helge Angelsen and Kim Waardal, Bergen

13.50 - 14.10 Robotic HPB surgery - the Stockholm experience after 500 resections. Stephan Gilg, Stockholm

14.10 - 14.30 Robotic pancreatoduodenectomy: Fully robotic vs robot assisted? Bergtor Björnsson, Linköping

14.30 - 14.45 A critical appraisal of robotic vs. laparoscopic HPB surgery. Åsmund Fretland, Oslo

14.45 - 15.00 Plenary discussion "Is robotic surgery to the best for the patient, for the surgeon, or for both?" TBA

15.00 – 15.30     Coffee/exhibition

15.30 – 16.30  Young investigators: Free papers I

Chair:Oddvar Sandvik

15.30 - 15.40 I: Impact of pancreas transection site on incidence of PF after distal pancreatectomy: a propensity score matched study. Trond Kjeseth, Stavanger 

15.40 - 15.50 II: Liver ablation, results from University of Northern Norway, Tromsø Brage Bårdsen, Tromso

15.50 - 16.00 III: International external validation and model update for the distal pancreatectomy fistula risk scores (DISPAIR and D-FRS) Akseli Bonsdorff, Helsinki

16.00 - 16.10 IV: Preoperative fistula risk score for pancreatoduodenectomy – Nordic multicenter study. Tiia Ojala, Helsinki

16.10 - 16.20 V: Experimental treatment for non-resectable CRLM: the Excalibur trial. Anne Longva, Oslo

16.20 - 16.30 VI: Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the outcome of pancreatic cancer patients: a retrospective populational study, Anni Varhe, Helsinki

16.30 – 16.40 Short break

16.40 – 17.00      Most important papers in HPB 2023-2024, Ville Sallinen, Helsinki

17.00 – 17.20      General Assembly of Nordic Chapter of IHPBA, Roland Andersson, Lund

17.20 - 18.00 Nordic Pancreatic Cancer Network, Roland Andersson, Lund

19.30 - 22.00       Dinner at Hotel Norge

Friday 20 September

NOLCA Chair: Per Stål and Malin Sternby Eilard

08.30 - 08.35 Welcome, Per Stål, Stockholm

08.35 - 09.00 Diagnosis and staging of HCC in cirrhotic and noncirrhotic liver with an emphasis on LIRADS, Nikolaos Kartalis, Stockholm

09.00 - 09.20 Adjuvant (or neoadjuvant) treatment following resection or ablation of HCC, Pia Österlund, Helsinki

09.20 - 09.35 Risk factors for recurrence after curative intent treatments of HCC, Peter Jepsen, Aarhus

09.35 - 09.50 HCC screening in Sweden – a case-control study on the impact of ultrasound screening on HCC- related mortality, Hannes Hegmar, Stockholm

09.50 - 10.15 Coffee break

 

Chair: Åsmund Avdem Fretland and Ida Björk

10.15 - 10.30 TESLA-trial: Liver transplantation for CCA, Sheraz Yaqub, Oslo

10.30 - 10.45 TOMCAT-trial: SIRT og HAI for CCA, Kristoffer Lassen, Oslo

10.45 - 11.00 Klatskin tumor: pre- and postoperative prognostic factors, Hasan Ahmad Al-Saffar, Copenhagen

11.00 - 11.30 State of the art lecture: Perioperative therapy for cholangiocarcinoma, Flavio Rocha, Oregon, USA

11.30 - 11.45 General Assembly NOLCA, Per Stål, Stockholm

11.45 - 12.45 Lunch and exhibition

Chair: Sheraz Yaqub

12.45 - 13.00 Risk of HCC and CCA in Danish and English patients with ALD cirrhosis, Morten D Jensen, Aarhus

13.00 - 13.15 Gall bladder cancer in Finland, Sini Takala, Helsinki

COLORECTAL LIVER METASTASES

13.15 - 13.35 Simultaneos resection for CLM - Results from a Norwegian national cohort of 200 patients, Jon-Helge Angelsen, Bergen

13.35 - 13.55 Metachronous recurrence pattern in 5500 patients from Central Norway, radically treated for colorectal cancer 2001-2015, Per Eivind Storli, Trondheim

13.55 - 14.00 Summing up, Roland Andersson and Jon-Helge Angelsen